Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong · Delayed Price · Currency is HKD 9.56
-0.24 (-2.45%)
At close: Feb 24, 2026
Medlive Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 323.77 | 315.15 | 242.3 | 117.32 | 40.62 | 85.2 |
Depreciation & Amortization | 17.01 | 13.2 | 9.22 | 8 | 5.91 | 5.32 |
Other Amortization | 2.4 | 2.4 | 0.16 | 0.99 | 0.24 | - |
Loss (Gain) From Sale of Assets | - | - | 0 | 0.09 | 0.09 | - |
Loss (Gain) on Equity Investments | - | - | -0.01 | -0.01 | 0 | - |
Stock-Based Compensation | 3.76 | 5.67 | 10.42 | 17.25 | 14.26 | - |
Provision & Write-off of Bad Debts | 0.51 | 0.51 | 0.51 | -0.23 | 0.51 | -0.51 |
Other Operating Activities | -192.65 | -200.04 | -182.74 | -56.64 | 10.66 | 3.21 |
Change in Accounts Receivable | -52.76 | -19.44 | -16.32 | -25.05 | -31.71 | 1.19 |
Change in Inventory | - | 0.1 | 0.1 | -0.11 | -0.09 | - |
Change in Accounts Payable | 7.83 | -0.91 | 6.25 | -4.17 | -0.75 | 3.63 |
Change in Other Net Operating Assets | 44.77 | -8.32 | 31.98 | 19.75 | 4.7 | 13.01 |
Operating Cash Flow | 154.64 | 108.32 | 101.87 | 77.19 | 44.43 | 111.05 |
Operating Cash Flow Growth | 68.20% | 6.33% | 31.97% | 73.72% | -59.99% | 293.75% |
Capital Expenditures | -20.99 | -11.96 | -0.75 | -1.35 | -1.97 | -0.63 |
Sale of Property, Plant & Equipment | - | 0.02 | - | - | - | - |
Cash Acquisitions | -13.87 | -10.03 | -56.39 | -42.6 | -52.95 | - |
Sale (Purchase) of Intangibles | -2.7 | -8.92 | -31.78 | -6.14 | - | - |
Investment in Securities | 121.34 | -35.64 | -700.03 | -3,580 | 0.03 | 0.64 |
Other Investing Activities | 189.67 | 177.55 | 154 | 44.23 | 4.36 | - |
Investing Cash Flow | 273.45 | 111.02 | -634.95 | -3,586 | -50.54 | 0.01 |
Short-Term Debt Issued | - | - | - | - | 6.45 | - |
Total Debt Issued | - | - | - | - | 6.45 | - |
Short-Term Debt Repaid | - | - | - | - | -6.45 | - |
Long-Term Debt Repaid | - | -12.92 | -5.54 | -5.01 | -3.76 | -2.63 |
Total Debt Repaid | -15.55 | -12.92 | -5.54 | -5.01 | -10.22 | -2.63 |
Net Debt Issued (Repaid) | -15.55 | -12.92 | -5.54 | -5.01 | -3.76 | -2.63 |
Issuance of Common Stock | 2.25 | 2.25 | 5.94 | 0 | 4,033 | - |
Repurchase of Common Stock | - | - | -0.68 | - | - | - |
Common Dividends Paid | -188.42 | -179.04 | -124.69 | -12.13 | -92 | - |
Other Financing Activities | -6.23 | -8.18 | -8.16 | -5.24 | -145.33 | -0.21 |
Financing Cash Flow | -207.96 | -197.89 | -133.13 | -22.38 | 3,792 | -2.83 |
Foreign Exchange Rate Adjustments | 16.89 | 57.63 | 63.06 | 329.89 | -53.93 | -0.02 |
Net Cash Flow | 237.02 | 79.08 | -603.15 | -3,201 | 3,732 | 108.21 |
Free Cash Flow | 133.66 | 96.36 | 101.12 | 75.84 | 42.47 | 110.42 |
Free Cash Flow Growth | 48.00% | -4.71% | 33.32% | 78.60% | -61.54% | 328.37% |
Free Cash Flow Margin | 21.32% | 17.25% | 24.54% | 24.15% | 14.93% | 51.71% |
Free Cash Flow Per Share | 0.18 | 0.13 | 0.14 | 0.10 | 0.07 | 0.21 |
Cash Interest Paid | 0.86 | 0.79 | 0.36 | 0.53 | 0.54 | 0.21 |
Cash Income Tax Paid | 11.33 | 11.02 | 11.81 | 9.33 | 14.16 | 15.2 |
Levered Free Cash Flow | 89.56 | 46.04 | 48.96 | 43.61 | 64.42 | 89.28 |
Unlevered Free Cash Flow | 90.1 | 46.53 | 49.19 | 43.94 | 64.75 | 89.41 |
Change in Working Capital | -0.16 | -28.57 | 22.01 | -9.57 | -27.85 | 17.83 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.